Source: Blood. Conference titles: Annual Meeting and Exposition of the American Society of Hematology. Unidades: FM, FCF
Subjects: POLIMORFISMO, ABORTO ESPONTÂNEO
ABNT
BERTINATO, Juliano Felix et al. Polymorphisms in thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor type 1 in women with primary recurrent pregnancy loss. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 20 ago. 2024. , 2013APA
Bertinato, J. F., Morelli, V. M., Wataru, G. G., Amorim Filho, A. G., Carvalho, M. H. B. de, Zugaib, M., & Guerra-Shinohara, E. M. (2013). Polymorphisms in thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor type 1 in women with primary recurrent pregnancy loss. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo.NLM
Bertinato JF, Morelli VM, Wataru GG, Amorim Filho AG, Carvalho MHB de, Zugaib M, Guerra-Shinohara EM. Polymorphisms in thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor type 1 in women with primary recurrent pregnancy loss. Blood. 2013 ; 122( 21):[citado 2024 ago. 20 ]Vancouver
Bertinato JF, Morelli VM, Wataru GG, Amorim Filho AG, Carvalho MHB de, Zugaib M, Guerra-Shinohara EM. Polymorphisms in thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor type 1 in women with primary recurrent pregnancy loss. Blood. 2013 ; 122( 21):[citado 2024 ago. 20 ]